Japan Orthopedic Regenerative Surgical Products Market Size & Outlook
Japan orthopedic regenerative surgical products market, 2016-2030 (US$M)
Related Markets
Japan orthopedic regenerative surgical products market highlights
- The Japan orthopedic regenerative surgical products market generated a revenue of USD 333.3 million in 2022 and is expected to reach USD 494.2 million by 2030.
- The Japan market is expected to grow at a CAGR of 5% from 2023 to 2030.
- In terms of segment, viscosupplements was the largest revenue generating product in 2022.
- Allografts is the most lucrative product segment registering the fastest growth during the forecast period.
Orthopedic regenerative surgical products market data book summary
| Market revenue in 2022 | USD 333.3 million |
| Market revenue in 2030 | USD 494.2 million |
| Growth rate | 5% (CAGR from 2022 to 2030) |
| Largest segment | Viscosupplements |
| Fastest growing segment | Allografts |
| Historical data | 2016 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Allografts, Synthetic, Cell-based, Viscosupplements |
| Key market players worldwide | Anika Therapeutics Inc, Vericel Corp, Baxter International Inc, Zimmer Biomet Holdings Inc, Stryker Corp, Smith & Nephew PLC, BioTissue, MiMedx Group Inc, Arthrex, AlloSource, VSY Biotechnology, Aptissen |
Other key industry trends
- In terms of revenue, Japan accounted for 8.0% of the global orthopedic regenerative surgical products market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan orthopedic regenerative surgical products market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 137.6 million by 2030.
Key Regions: Brazil , U.S. , UK , South Africa , Saudi Arabia
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Orthopedic Regenerative Surgical Products Market Scope
Orthopedic Regenerative Surgical Products Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan orthopedic regenerative surgical products market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic regenerative surgical products market will help companies and investors design strategic landscapes.
Viscosupplements was the largest segment with a revenue share of 49.62% in 2022. Horizon Databook has segmented the Japan orthopedic regenerative surgical products market based on allografts, synthetic, cell-based, viscosupplements covering the revenue growth of each sub-segment from 2016 to 2030.
The country has the oldest population in the region. As per internal affairs ministry, the estimated number of individuals aged 65 or older in the country was at a record high of 36.4 million as of September 2021, an increase of 220,000 from last year.
Furthermore, various initiatives being undertaken by the players are contributing to growth of the country’s market. For instance, in June 2021, MiMedx’s EPIFIX allografts received regulatory clearance from the Ministry of Health, Labour and Welfare (JMHLW) in Japan, enabling it to commercialize its products.
Moreover, in September 2021, Asahi Kasei Pharma Corporation entered in to an exclusive option agreement with AgNovos Healthcare, LLC for the commercialization of AGN1 LOEP Hip Kit in Japan. Preclinical and clinical research validated that treatment with the AGN1 LOEP Hip Kit leads to new bone formation, which raises strength of osteoporotic femur.
Reasons to subscribe to Japan orthopedic regenerative surgical products market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan orthopedic regenerative surgical products market databook
-
Our clientele includes a mix of orthopedic regenerative surgical products market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan orthopedic regenerative surgical products market , including forecasts for subscribers. This country databook contains high-level insights into Japan orthopedic regenerative surgical products market from 2016 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan orthopedic regenerative surgical products market size, by product, 2016-2030 (US$M)
Japan Orthopedic Regenerative Surgical Products Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
